PNU-159682-P1C1TM | m-entrepreneurship.com

Product Name :
PNU-159682-P1C1TM

Search keywords :
PNU-159682

drugId :
null

Target Vo:
Tumor protein p53

Target Vo Short Name :
p53

Moa_Name:
Tumor protein p53 stimulants

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Singapore Immunology Network

Active Company_Name :
Singapore Immunology Network

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Glucocorticoid Receptor Antibody
Glutathione Peroxidase 1 Antibody (YA404)
Cytokeratin 20 Antibody: Cytokeratin 20 Antibody is an unconjugated, approximately 44 kDa, rabbit-derived, anti-Cytokeratin 20 monoclonal antibody. Cytokeratin 20 Antibody can be used for: WB, IHC-P, ICC/IF, IP, FC expriments in human, rat background without labeling.

Author: Betaine hydrochloride

Related Posts